Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

KNSAKNSA
8 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in KINIKSA PHARMACEUTICALS INTL

DEUTSCHE BANK AG\ holds 387,606 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $24.8M as of 2026-Q2. The position was decreased (-26.0% shares). KNSA represents 0.0% of DEUTSCHE BANK AG\'s portfolio.

Current Value

$24.8M

Current Shares

387,606

Total Value Change

+$22.8M

Total Shares Change

+307,292

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
387,606
-26.0%
$24.8M0.0%$63.95
0
2026-Q1
Decreased
523,691
-16.9%
$25.2M0.0%$45.37
0
2025-Q4
Increased
630,291
+18.2%
$26M0.0%$40.99
34
2025-Q3
Increased
533,375
+44.4%
$20.7M0.0%$38.77
38
2025-Q2
Decreased
369,502
-6.3%
$10.2M0.0%$28.04
0
2025-Q1
Increased
394,522
+177.1%
$8.8M0.0%$23.09
44
2024-Q4
Increased
142,397
+77.3%
$2.8M0.0%$19.60
40
2024-Q3
New
80,314
-
$2M0.0%$25.00
36

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used